MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,414,545 | +136.4% | 119,500 | +264.3% | 0.78% | +401.3% |
| Q3 2022 | $2,290,376 | +90.9% | 32,800 | +124.7% | 0.16% | +358.8% |
| Q1 2022 | $1,200,000 | -93.1% | 14,600 | -87.7% | 0.03% | -90.4% |
| Q4 2021 | $17,456,000 | -49.1% | 119,000 | -38.7% | 0.35% | -66.0% |
| Q3 2021 | $34,321,000 | +786.6% | 194,000 | +758.4% | 1.04% | +972.2% |
| Q1 2021 | $3,871,000 | -86.3% | 22,600 | -82.4% | 0.10% | -81.9% |
| Q4 2020 | $28,223,000 | +1316.1% | 128,500 | +970.8% | 0.54% | +635.6% |
| Q3 2020 | $1,993,000 | +132.8% | 12,000 | +60.0% | 0.07% | +23.7% |
| Q2 2020 | $856,000 | +102.4% | 7,500 | +36.4% | 0.06% | +3.5% |
| Q1 2020 | $423,000 | – | 5,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |